The Upstream Bioprocessing Market size was estimated USD 19.48 billion in 2023 and is expected to reach USD 67.04 billion by 2031 at a CAGR of 16.7% during the forecast period of 2024-2031. The upstream bioprocessing market, a critical segment within the biopharmaceutical industry, is experiencing robust growth driven by the increasing demand for biologics, vaccines, and personalized medicine....
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian